- Udyam number
- UDYAM-MH-17-0011153

About Maxwell Life Science Limited
Data last updated:
Maxwell Life Science Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 25 May 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2004PLC146536. Its GSTIN is 27AAECM0706E1ZX (Maharashtra).
The company has an authorised share capital of ₹22.3 Cr and a paid-up capital of ₹15.79 Cr. It is led by directors including Sanjay Bastimal Surana (Managing Director) and Neetu Sanjay Surana (Whole-Time Director).
Its last annual general meeting (AGM) was held on 21 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹136.55 Cr, a growth of 67% compared to the previous year. For the same year it recorded a net profit of ₹8.99 Cr (net margin 6.6%) and EBITDA of ₹15.32 Cr (EBITDA margin 11.2%). Revenue has grown at a compounded annual rate (CAGR) of 67% over three years and 37% over five years.
The company has about 22 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Maxwell Life Science Limited. As per MCA filings, the company has open charges of ₹21.37 Cr and satisfied charges of ₹14.61 Cr on record. Court records list 14 cases involving the company, including 2 filed by the company and 12 filed against it; 6 cases are pending.
Maxwell Life Science Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-17-0011153). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mlspl.in.
Company details
CIN history
Maxwell Life Science has one previous CIN (Corporate Identification Number): U24230MH2004PTC146536. The current CIN is U24230MH2004PLC146536, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH2004PLC146536 | Current |
| U24230MH2004PTC146536 | Previous |
Recognitions & Rankings of Maxwell Life Science
Contact details
Maxwell Life Science Limited's registered office is in Mumbai, Maharashtra. Its website is mlspl.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressOffice No. 401 402 & 403 4th Floor, Target Mall Chandavarkar Road, Mumbai, Maharashtra, India – 400092
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Maxwell Life Science Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Maxwell Life Science operates one associated brand: Maxwell Life Science Limited. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and exporting of pharmaceutical formulations. | mlspl.in |
Business activity
The main business activity of Maxwell Life Science is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Maxwell Life Science Limited, buy the company report.
Financials of Maxwell Life Science Limited
FY 2024 filings availableMaxwell Life Science Limited reported revenue of ₹136.55 Cr (up 67% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 37% over five years, including 67% growth in the latest year. EBITDA rose 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.32 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.99 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.2% | ||||
| Net Profit Margin | 6.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maxwell Life Science Limited, buy the company report.
Board of directors of Maxwell Life Science Limited
Maxwell Life Science has 5 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Bastimal Surana Also directs: Victo Nutras LLP | Managing Director | 25 May 2004 | 22 Years 4 Months | Current |
| Rajendra Runwal | Director | 18 Mar 2024 | 2 Years 7 Months | Current |
| Vijay Kumar Sagarmal Singhavi | Director | 18 Mar 2024 | 2 Years 7 Months | Current |
| Neetu Sanjay Surana Also directs: Victo Nutras LLP | Whole-Time Director | 30 Mar 2015 | 11 Years 6 Months | Current |
| Nayankant Hasmukhlal Gadoya | Director | 20 Mar 2025 | 1 Years 7 Months | Current |
Peer comparison
Maxwell Life Science Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ontop Pharmaceuticals Private Limited | ₹138.93 Cr (FY 2024) | 4.0% | Hosur Road, Bangalore, Karnataka, India | |||
| Sundyota Numandis Probioceuticals Private Limited | ₹138.84 Cr (FY 2025) | 24.0% | Ahmedabad, Gujarat, India | |||
| M.M. Remedies Private Limited | ₹137.33 Cr (FY 2025) | 10.0% | Llucknow, Uttar Pradesh, India | |||
| Palsons Derma Private Limited | ₹137.11 Cr (FY 2025) | 15.0% | Kolkata, West Bengal, India | |||
| Maxwell Life Science Limitedthis company | ₹136.55 Cr (FY 2025) | ₹8.99 Cr | 6.6% | 67.0% | 22 | Mumbai, Maharashtra, India |
| Lewens Labs Private Limited | ₹136.52 Cr (FY 2025) | 12.0% | Bharuch, Gujarat, India | |||
| Naari Pharma Private Limited | ₹136.35 Cr (FY 2025) | 14.0% | Bangalore, Karnataka, India | |||
| Zenith Drugs Limited | ₹135.93 Cr (FY 2025) | 2.0% | Indore, Madhya Pradesh, India | |||
| Alpa Laboratories Limited | ₹135.8 Cr (FY 2025) | 10.0% | Indore, Madhya Pradesh, India | |||
| Ravoo's Laboratories Limited | ₹134.97 Cr (FY 2024) | 4.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Maxwell Life Science Limited, buy the company report.
Auditor
Maxwell Life Science Limited is audited by JPJ ASSOCIATES LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JPJ ASSOCIATES LLP | FY 2024 | 113012W/W100296 |
Shareholding
The shareholding of Maxwell Life Science Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Maxwell Life Science Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Sep 2025 | 101151404 | Others | ₹1.32 Cr | Open | |
| 04 Sep 2025 | 101151400 | Others | ₹31.5 Lakh | Open | |
| 23 May 2025 | 101099026 | Others | ₹3 Cr | Open | |
| 01 Nov 2023 | 100811585 | The Bharat Co-Operative Bank(Mumbai) Ltd | ₹70 Lakh | Open | |
| 31 Jan 2023 | 100682664 | The Bharat Co-Operative Bank(Mumbai) Ltd | ₹1.25 Cr | Open |
To see the full charge records of Maxwell Life Science Limited, buy the company report.
Total charge records: 15 View all charges
Legal cases
Maxwell Life Science Limited has 14 court cases on record: 2 filed by Maxwell Life Science, 12 filed against it. 6 cases are pending and 8 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 8 | 7 | 5 |
| District courts | 6 | 5 | 1 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Amico Formulations LLP and 1 other | Pending |
| High Court, MAHARASHTRA | Court case (CRR) | Filed against the company by Socomed Pharma Pvt.Ltd. | Pending |
| District court, Hyderabad CCC, Telangana | Cheque dishonour complaint | Filed against the company by M/S. Tagoor Laboratories Pvt. Ltd, Rep.By Mr.G.Mohan Rao | Disposed |
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Socomed Pharma Pvt.Ltd. | Disposed |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed against the company by Socomed Pharma Pvt.Ltd. | Disposed |
To see the full case history of Maxwell Life Science Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maxwell Life Science Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Maxwell Life Science Limited has a workforce of 22 employees on its EPFO records as of Feb 27, 2025, across 1 active EPFO establishment.
GST
Maxwell Life Science has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECM0706E1ZX | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Maxwell Life Science Limited, buy the company report.
Recent activity
Maxwell Life Science Limited has 14 board changes on record since 2004: 5 appointments and 9 cessations. The latest: Nayankant Hasmukhlal Gadoya ceased to be Additional Director on 01 Apr 2025.
33 earlier events are in the company report.
Frequently asked questions
Maxwell Life Science is an active public limited company based in Mumbai, Maharashtra, India. The company works in chemical products, within the chemicals industry. It was incorporated on 25 May 2004 (22+ years old) and is registered under CIN U24230MH2004PLC146536.
Maxwell Life Science has 5 current directors:
- Sanjay Bastimal Surana - Managing Director
- Neetu Sanjay Surana - Whole-Time Director
- Rajendra Runwal - Director
- Vijay Kumar Sagarmal Singhavi - Director
- Nayankant Hasmukhlal Gadoya - Director
The latest financial statements of Maxwell Life Science on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 21 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Maxwell Life Science is 27AAECM0706E1ZX, registered in Maharashtra.
The CIN (Corporate Identification Number) of Maxwell Life Science is U24230MH2004PLC146536. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxwell Life Science has 14 court cases on record: 2 filed by the company and 12 filed against it. 6 are pending. Most are in the high courts.
Maxwell Life Science was incorporated on 25 May 2004, making it 22+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Maxwell Life Science by revenue are Ontop Pharmaceuticals Private Limited, Sundyota Numandis Probioceuticals Private Limited, M.M. Remedies Private Limited, Palsons Derma Private Limited, Lewens Labs Private Limited and 4 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Nayankant Hasmukhlal Gadoya ceased to be Additional Director on 01 Apr 2025. Nayankant Hasmukhlal Gadoya was appointed as Director on 20 Mar 2025. Piyush Narayan Trivedi ceased to be Director on 11 Mar 2025. Maxwell Life Science has 14 board changes on record in total.
Yes, Maxwell Life Science is registered as an MSME under Udyam registration (number: UDYAM-MH-17-0011153).
Maxwell Life Science can be reached through the website mlspl.in. Its registered office is in Mumbai, Maharashtra, India.